 |
June 30, 2010 : |
Published Paper Reporting the Results from Collategene Phase III Clinical Trial Performed in
Japan Receives the Research Achievement Award of the Asian Society for Vascular Surgery |
|
April 21, 2010 : |
Medical Journal Publication of Data from "Collategene" Phase III Clinical Study Performed in Japan |
|
December 25, 2009 : |
Issuance of Notice of Termination of the License Agreement with Transcription Factor Therapeutics, LLC, on NF-κB Decoy |
|
November 24, 2009 : |
Agreement on SPA with the US FDA for Phase III Clinical Trial for CollategeneTM,
a Drug for Ischemic Disease Treatment |
|
November 24, 2009 : |
Agreement on SPA with the US FDA for Phase III Clinical Trial for CollategeneTM,
a Drug for Ischemic Disease Treatment |
|
November 24, 2009 : |
Product Patent on Dumbbell-Type (Ribbon-Type) E2F Decoy Oligonucleotide Granted in Japan
--- Covering a Circular Oligonucleotide Sequence --- |
|
October 22, 2009 : |
Patent on New Decoy Oligonucleotide Granted in Japan
—Covering NF-κB/ets chimera (double) decoy— |
|
September 3, 2009 : |
AnGes MG Project Adopted by NEDO as Next Generation Strategic Business Program
– Development of Drug-Eluting PTA Balloon Catheter – |
|
August 31, 2009 : |
Project of AnGes MG Subsidiary GenomIdea Adopted as Strategic Basic Technology Sophistication Supportive Program - R&D of New Method for Biopharmaceuticals Manufacturing Using Technology to Maintain Vacuum - |
|
July 29, 2009 : |
Medical-Use Patent on NF-κB Decoy Oligonucleotide Granted in Japan
- Covering Psoriasis - |
|
July 14, 2009 : |
AnGes Project Selected by R&D Project for Creation of Regional Innovation
-Development of Medical Products Based on Functional Peptides Derived from Plant
Regeneration Mechanism- |
|
April 27, 2009 : |
Joint R&D with Morishita Jintan Co., Ltd.
-Development of New Products Based on
Functional Peptides with Antimicrobial Activity- |
|
April 23, 2009 : |
Intellectual Property Report was updated |
|
April 15, 2009 : |
Substance Patent on Dumbbell-Type (Ribbon-Type)
NF-κB Decoy Oligonucleotide Granted in Japan
-Covering a Circular Oligonucleotide Sequence- |
|
March 26, 2009 : |
AnGes Project Adopted to Receive NEDO Support
- Development of Novel Disinfectants with Antibacterial Peptides - |
|
March 2, 2009 : |
AnGes Reached a Broad Agreement with the FDA on the Clinical Trial Designs for Their Phase III Study with Collategene™ |
|
February 16, 2009 : |
Announcement about the progress of Allovectin-7® Phase 3 pivotal trial |
|
February 6, 2009 : |
AnGes MG continues the collaborations of plasmid HGF for Japan market with
Daiichi-Sankyo while the US/Europe marketing rights are returned |
 |
February 4, 2009 : |
Efficacy of NF-κB decoy oligodeoxynucleotides for periodontal disease confirmed in an animal study
-An academic paper published in the scientific journal, Antioxidants & Redox Signaling- |
|
February 2, 2009 : |
GenomIdea, a Subsidiary of AnGes MG, Signs a Licensing Contract for GEN0101 |
| |
|
|
